Pairwise drug combinations were tested for synergistic effects using MTT-based cell viability data of tumor cell lines exposed for 48 h to four different concentrations of either cisplatin and doxorubicin or cisplatin and mebendazole (all from Selleckchem). Maximum synergy scores and the corresponding concentrations were determined using the HSA statistical reference model of the Synergyfinder 2.0 software [24 (link)].
Free full text: Click here